Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 SAD Study of DS-1971a in Healthy Male Subjects
NCT02107885Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in neuropathic pain comparing DS-1971 with Placebo (2 arms). Primary endpoints: safety and tolerability adverse events, safety and tolerability physical exam and 1 more. Started Mar 2014; status: completed.
02
Drugs
DS-1971
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02107885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107885.